New Fundings And Goals To Match Raised In Latest MDUFA IV Session
This article was originally published in The Gray Sheet
As the number of de novo applications and pre-submission consultations keep growing, FDA is proposing to institute provide new funding for these programs, among a range of additional proposals laid out in a recent closed-door negotiation. The agency's plan aligns somewhat with an industry proposal, according to meeting minutes, but there is also a lot to negotiate.
Register for our free email digests: